PMV Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PMV Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q3 2025.
  • PMV Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $891K, a 89.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

PMV Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $891K -$7.52M -89.4% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $977K -$7.06M -87.8% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $1.06M -$7.15M -87.1% Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $1.14M -$7.24M -86.4% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $8.41M -$138K -1.62% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $8.04M -$691K -7.92% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.21M -$919K -10.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.38M -$1.16M -12.1% Dec 31, 2023 10-K 2025-03-03
Q3 2023 $8.55M -$990K -10.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $8.73M -$941K -9.73% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $9.13M -$606K -6.22% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $9.54M -$521K -5.18% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $9.54M -$875K -8.41% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $9.67M -$1.09M -10.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $9.74M +$8.91M +1076% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $10.1M Dec 31, 2021 10-K 2023-03-01
Q3 2021 $10.4M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $10.8M Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $828K Mar 31, 2021 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.